Discover how monoclonal antibody 4C5 inhibits melanoma metastasis through groundbreaking research findings and experimental data.
Breakthrough in breast cancer treatment with FDA approval of fam-trastuzumab deruxtecan-nxki (Enhertu) for HER2-low and HER2-ultralow metastatic breast cancer.